re: Ann: PolyNovo Concludes Recruitment for V...
main points from http://www.metabolic.com.au/ 4 February 2013 PolyNovo Concludes Recruitment for the NovoSorb™ VAC Clinical Trial ? Final patient recruited in the NovoSorb™ Vacuum Assisted Closure (VAC) Clinical Study, ? Results expected within 75 days, ? Positive results will support PolyNovo’s application for Marketing Approval in the United States of America (via a 510(k) Clearance Pathway), ? PolyNovo expects to file for 510(k) clearance in the USA in Q3, 2013.
CZD Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held